Literature DB >> 16444412

Ticks, ivermectin, and experimental Chagas disease.

João Carlos Pinto Dias1, Christopher J Schofield, Evandro Mm Machado, Alexandre José Fernandes.   

Abstract

Following an infestation of dogticks in kennels housing dogs used for long-term studies of the pathogenesis of Chagas disease, we examined the effect of ivermectin treatment on the dogs, ticks, trypanosome parasites, and also on triatomine vectors of Chagas disease. Ivermectin treatment was highly effective in eliminating the ticks, but showed no apparent effect on the dogs nor on their trypanosome infection. Triatominae fed on the dogs soon after ivermectin treatment showed high mortality, but this effect quickly declined for bugs fed at successive intervals after treatment. In conclusion, although ivermectin treatment may have a transient effect on peridomestic populations of Triatominae, it is not the treatment of choice for this situation. The study also showed that although the dogticks could become infected with Trypanosoma cruzi, this only occurred when feeding on dogs in the acute phase of infection, and there was no evidence of subsequent parasite development in the ticks.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16444412     DOI: 10.1590/s0074-02762005000800002

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  7 in total

1.  Efficacy of deltamethrin, diazinon, and ivermectin on Boophilus annulatus ticks (in vitro and in vivo study).

Authors:  Nasr M El-Bahy; Eman K Bazh; Hazem M Shaheen
Journal:  Parasitol Res       Date:  2014-11-15       Impact factor: 2.289

Review 2.  Chronic Chagas' heart disease: a disease on its way to becoming a worldwide health problem: epidemiology, etiopathology, treatment, pathogenesis and laboratory medicine.

Authors:  Silvia Gilka Muñoz-Saravia; Annekathrin Haberland; Gerd Wallukat; Ingolf Schimke
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

Review 3.  Broadening the range of use cases for ivermectin - a review of the evidence.

Authors:  Christian Kositz; John Bradley; Harry Hutchins; Anna Last; Umberto D'Alessandro; Michael Marks
Journal:  Trans R Soc Trop Med Hyg       Date:  2022-03-02       Impact factor: 2.455

4.  Canine vector-borne diseases in Brazil.

Authors:  Filipe Dantas-Torres
Journal:  Parasit Vectors       Date:  2008-08-08       Impact factor: 3.876

5.  Broadening the spectrum of ivermectin: Its effect on Trypanosoma cruzi and related trypanosomatids.

Authors:  Laura Fraccaroli; María Daniela Ruiz; Virginia Gabriela Perdomo; Agustina Nicole Clausi; Darío Emmanuel Balcazar; Luciana Larocca; Carolina Carrillo
Journal:  Front Cell Infect Microbiol       Date:  2022-07-28       Impact factor: 6.073

6.  In vitro anti-trypanosomal effect of ivermectin on Trypanosoma evansi by targeting multiple metabolic pathways.

Authors:  Snehil Gupta; Sukhdeep Vohra; Khushboo Sethi; Surbhi Gupta; Bidhan Chandra Bera; Sanjay Kumar; Rajender Kumar
Journal:  Trop Anim Health Prod       Date:  2022-07-22       Impact factor: 1.893

7.  Understanding the widespread use of veterinary ivermectin for Chagas disease, underlying factors and implications for the COVID-19 pandemic: a convergent mixed-methods study.

Authors:  Boris Apodaca Michel; Miriam Navarro; Michael Pritsch; Jeremy Douglas Du Plessis; Jonathan Shock; Eva-Maria Schwienhorst-Stich; Janina Zirkel; Hanna Schrader; Claudia Saavedra Irala; Gonzalo Rubilar; Carolin Gunesch; Christa Kasang; Thomas Zoller; Ildiko Gagyor; Sandra Parisi
Journal:  BMJ Open       Date:  2022-09-17       Impact factor: 3.006

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.